As schools reopen it should be safe for most immunosuppressed paediatric oncology patients to return to the classroom, according to advice from the Australia and New Zealand Children’s Haematology/Oncology Group (ANZCHOG). However the group acknowledges that return to school decisions in relation to COVID-19 risk are complex for families of children who are receiving or ...
Back to school advice for paediatric oncology patients
By Michael Woodhead
26 May 2020